Kalbe Farma Ownership

KLBF Stock  IDR 1,215  20.00  1.62%   
Kalbe Farma Tbk maintains a total of 46.26 Billion outstanding shares. Kalbe Farma Tbk holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Kalbe Stock Ownership Analysis

About 58.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 72.54. Kalbe Farma Tbk last dividend was issued on the 31st of May 2022. The entity had 5:1 split on the 8th of October 2012. To find out more about Kalbe Farma Tbk contact the company at 62 21 4287 3888 or learn more at https://www.kalbe.co.id.

Kalbe Farma Outstanding Bonds

Kalbe Farma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kalbe Farma Tbk uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kalbe bonds can be classified according to their maturity, which is the date when Kalbe Farma Tbk has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Kalbe Stock

Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.